Core Viewpoint - The article does not provide any specific insights or analysis related to a company or industry, focusing instead on the author's qualifications and disclosures [1][2][3]. Group 1 - The author holds multiple degrees in engineering, computer science, business management, and computer applications from various institutions [1]. - The author collaborates with another professional but emphasizes independent analysis and adherence to guidelines [1]. - There is a clear statement of no current stock or derivative positions in any mentioned companies, indicating a lack of conflict of interest [2]. Group 2 - The article includes disclaimers about past performance not guaranteeing future results and clarifies that no investment advice is being provided [3]. - It highlights that the views expressed may not reflect those of the platform as a whole, indicating a diversity of opinions among contributors [3]. - The article notes that the analysts may not be licensed or certified, which could impact the credibility of the analysis [3].

Core Insights - Apyx Medical Corporation is showcasing its Renuvion technology at Miami Swim Week, emphasizing real patient transformations and the empowerment of individuals through body contouring solutions [1][2][3] Company Overview - Apyx Medical Corporation specializes in advanced energy technology, particularly its Helium Plasma Platform Technology, marketed as Renuvion, and the AYON Body Contouring System™ [5] - The company provides innovative products that enable surgeons to deliver controlled heat to tissue, supported by over 90 clinical documents [5] Product Highlights - Renuvion combines helium plasma and radiofrequency energy to achieve tissue contraction and collagen remodeling, making it a trusted tool for plastic surgeons globally [3] - The technology addresses loose skin concerns, which affect millions, offering a solution with minimal downtime [2][3] Marketing and Branding - The company aims to redefine beauty standards by highlighting real patient journeys and encouraging self-acceptance through its marketing efforts at major cultural events [3] - Apyx Medical's mission extends beyond aesthetics, focusing on restoring confidence to individuals struggling with loose skin [3]

CANTON, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Results Summary: Net revenue of $86.7 million for the first quarter of 2025, a decrease of $23.3 million compared to net r ...

Apyx Medical (APYX) Q1 2025 Earnings Call May 08, 2025 08:00 AM ET Company Participants Jeremy Feffer - Managing DirectorCharles Goodwin - President and Chief Executive OfficerMatthew Hill - Chief Financial Officer Conference Call Participants Matt Hewitt - Senior Research AnalystSam Eiber - Vice President and Medical Technology Analyst Operator Ladies and gentlemen, good morning, and welcome to the Apyx Medical First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in ...

Beloved Personality of "The Real Housewives of New Jersey" Provides a Real Take on the Problem of Loose Skin and the Power of Body Contouring TechnologyCLEARWATER, Fla., May 1, 2025 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® today announces Dolores Catania as the Chief of Confidence for the brand's Renew You consumer marketing campaign which exem ...

合作伙伴征集：2025全球手术机器人大会 报名：首届全球眼科大会 | 展位有限 报名：首届全球心血管大会 | 奖项评选 Prenuvo已组建了 超大 规模 的专注于全身MRI检测的私人放射学团队 ，旗下拥有 80余位 获得专业认证 的放射科医师。凭借这一专业优势，公司与多家顶尖学术机构建立了研究合作关系，通过将MRI技术与人 工智能创新性结合，共同推进健康、衰老及疾病领域的科学研究。 Prenuvo拥有大型全身MRI影像数据库，有大量机会构建模型，以 提高其检查的准确性，并使其80位放 射科医生的工作更加高效。 报名：首届全球骨科大会 | 奖项评选 近日，医疗科技初创公司Prenuvo宣布已筹集了1.2亿美元（合约8.72亿人民币），本轮融资由 Forerunner Ventures、Left Lane Capital和现有投资者Felicis共同领投。 资金将用于为 其全身核磁共振扫描平台增加模式和分析功能，Prenuvo透露，其新的人工智能身体成分 报告软件已获得FDA批准。 # 融 资详情 Prenuvo公司宣布，该公司已通过其平台为会员群体提供了超过 140万条 个性化健康洞察，会员数量已 突破 11 ...